Waldenstrom macroglobulinemia cells devoid of BTKC481S or CXCR4WHIM-like mutations acquire resistance to ibrutinib through upregulation of Bcl-2 and AKT resulting in vulnerability towards venetoclax or MK2206 treatment - Concepedia

Concepedia

Publication | Open Access

Waldenstrom macroglobulinemia cells devoid of BTKC481S or CXCR4WHIM-like mutations acquire resistance to ibrutinib through upregulation of Bcl-2 and AKT resulting in vulnerability towards venetoclax or MK2206 treatment

DOI Full Paper Access

54

Citations

39

References

2017

Year

Aneel Paulus, Sharoon Akhtar, Hamza Yousaf, Alak Manna, Shumail M. Paulus, Yamima Bashir, Thomas R. Caulfield, Maja K. Blake, Kasyapa S. Chitta, X Wang,

Blood Cancer Journal

References

	Year	Citations

Page 1